Anika Therapeutics
ANIK
ANIK
170 hedge funds and large institutions have $616M invested in Anika Therapeutics in 2018 Q1 according to their latest regulatory filings, with 20 funds opening new positions, 59 increasing their positions, 58 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
1% less funds holding
Funds holding: 172 → 170 (-2)
8% less capital invested
Capital invested by funds: $670M → $616M (-$53.9M)
100% less funds holding in top 10
Funds holding in top 10: 2 → 0 (-2)
Holders
170
Holding in Top 10
–
Calls
$1.76M
Puts
$1.42M
Top Buyers
| 1 | +$11.3M | |
| 2 | +$4.59M | |
| 3 | +$3.7M | |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$2.23M |
| 5 |
PCM
Portolan Capital Management
Boston,
Massachusetts
|
+$2.16M |
Top Sellers
| 1 | -$8.08M | |
| 2 | -$7.14M | |
| 3 | -$1.5M | |
| 4 |
HSA
Hussman Strategic Advisors
Ellicott City,
Maryland
|
-$1.35M |
| 5 |
ACM
Ativo Capital Management
Chicago,
Illinois
|
-$1.05M |